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ABSTRACT Human umbilical vein endothelial cell (HUVEC)-based gene expression studies performed under
hypoxia and/or hyperglycemia show huge potential for modeling endothelial cell response in cardiovascular
disease and diabetes. However, such studies require reference genes that are stable across the whole range of
experimental conditions. These reference genes have not been comprehensively defined to date. We applied
human genome-wide microarrays and quantitative real-time PCR (qRT-PCR) on RNA obtained from primary
HUVEC cultures that were incubated for 24 hr either in euglycemic or in hyperglycemic conditions and then
subjected to short-term CoCl2-induced hypoxia for 1, 3, or 12 hr. Using whole-transcript arrays, we selected
10 commonly used reference genes with no significant expression variation across eight different conditions.
These genes were ranked using NormFinder software according to their stability values. Consequently, five
genes were selected for validation by qRT-PCR. These were ribosomal protein large P0 (RPLP0), transferrin
receptor (TFRC), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), b-glucuronidase (GUSB), and b-actin
(ACTB). All five genes displayed stable expression under hyperglycemia. However, only RPLP0 and TFRC
genes were stable under hypoxia up to 12 hr. Under hyperglycemia combined with hypoxia up to 12 hr, the
expression of RPLP0, TFRC, GUSB, and ACTB genes remained unchanged. Our findings strongly confirm that
RPLP0 and TFRC are the most suitable reference genes for HUVEC gene expression experiments subjected to
hypoxia and/or hyperglycemia for the given experimental conditions. We provide further evidence that even
commonly known references genes require experimental validation for all conditions involved.
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Cardiovascular disease (CVD) remains the main cause of morbidity
and mortality in patients with diabetes mellitus (DM) (Ziche et al.
1997; Nakamura et al. 2006). With the advent of new pharmacological
agents for diabetes, active research to improve the clinical outcome of
CVD in those patients is ongoing. Impairment of endothelial repair is
recognized as an early event in the development of CVD; therefore,
in vitro studies involving human umbilical vein endothelial cells
(HUVEC) are important for studying molecular mechanisms involved
in CVD and the effect of potential new therapeutic agents.
A cardinal feature of CVD, particularly myocardial infarction, is
tissue hypoxia. In patients with diabetes there are several risk factors
involved in acute myocardial infarction, of which hypoxia, hypergly-
cemia, and the combination of both are fundamental and thus require
depth investigation. To study the molecular events in CVD and
diabetes, in vitro endothelial models considering the relevant con-
ditions and time intervals that reflect the clinical situations are cru-
cial. For accurate and reliable quantitative real-time PCR (qRT-PCR)
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results, normalization of data with reference genes is necessary.
Reference genes, otherwise known as housekeeping genes, have a sta-
ble expression level in the tissues or cells undergoing investigation or
different experimental conditions (Dheda et al. 2004; Huggett
et al. 2005). Genome-wide expression analyses are powerful tools
for a comprehensive gene screen of virtually all annotated genes
and simultaneously compare expression data between different sam-
ples. qRT-PCR is the technique of choice to validate gene expres-
sion data generated by microarray experiments (Mutch et al. 2001;
Provenzano and Mocellin 2007). Therefore, pilot studies are fre-
quently conducted to establish reference genes for varying in vivo
and in vitro conditions.
In the event of acute myocardial infarction/acute ischemia, cell
death takes place in as little as 20 min in some animal models, whereas
complete necrosis of all at-risk myocardial cells requires at least 2 to
4 hr or more (Jennings and Ganote 1974; Thygesen et al. 2007).
Therefore, hypoxic model systems using short-term cultures between
1 and 3 hr are of paramount importance to appropriately simulate the
time frame of acute ischemia. To date, no reference genes have been
established in HUVEC cultures under hypoxia and/or hyperglycemia.
Thus, the aim of our study was to determine reference genes in
HUVEC cultures mimicking clinical conditions.
MATERIALS AND METHODS
HUVEC cultures
The study was approved by The Biomedical Ethics Unit, Faculty of
Medicine, King Abdulaziz University (approval number 440-10) and
NRES Committee North East-Sunderland, UK (approval number 12/NE/
0044). Following informed consent, umbilical cords were collected from
normal deliveries and maintained in conservation buffer consisting of
50 ml DPBS containing 200 U/ml penicillin, 200 ug/ml streptomycin, and
2.5 ug/ml fungizone (PAA Laboratories, Buckinghamshire, UK). HUVEC
were harvested from four independent umbilical cords by collagenase
digestion (Roche, Basel, Switzerland) according to methods described by
Jaffe et al. (1973). All experiments were performed in passage 2 at 50% to
60% confluency. The microarray experiments were repeated three times
using three independent HUVEC samples for all tested conditions. The
qRT-PCR experiments were performed using four independent HUVEC,
three of which were the same as used in the microarray experiments.
Hypoxia studies
HUVEC were cultured under normoxia (21% O2) or chemically in-
duced hypoxia for 1, 3, and 12 hr using a final concentration of 150 mM
CoCl2 (Sigma-Aldrich, Dorset, UK) according to an established pro-
tocol (Sultana et al. 1999).
Hyperglycemia studies
HUVEC were cultured either with a euglycemic glucose concentration
of 5.5 mM (Sigma-Aldrich, Dorset, UK) as a control or with hyper-
glycemic glucose concentration of 16.5 mM for 24 hr to mimic diabetes.
Combined hyperglycemia and hypoxia studies
HUVEC were cultured for 24 hr under hyperglycemic conditions and
then hypoxia induced with CoCl2 for 1, 3, and 12 hr to mimic con-
ditions during myocardial infarction in a diabetic patient. A summary
of the experimental design is illustrated in Figure 1.
Total RNA extraction
Total RNA from HUVEC was extracted using the RNeasy Mini Kit
(QIAGEN, Hilden, Germany) according to the manufacturer’s
instructions. On-column DNase digestion with RNase-Free DNase set
(QIAGEN) was performed to remove genomic DNA contamination.
The quality and quantity of RNA were assessed using a NanoDrop
2000c Spectrophotometer (Thermo Scientific, Wilmington, DE). The
integrity of RNA samples was assessed by using Agilent 2100 Bioanalyzer
(Santa Clara, CA).
RNA sample preparation and microarray hybridization
Microarray experiments were performed using Affymetrix (Santa
Clara, CA) Human Gene 1.0 ST arrays according to the manufacturer’s
instructions with minor modifications (Merdad et al. 2014). For each
sample, 250 ng of total RNA was processed using the Affymetrix
GeneChip Whole Transcript Sense Target Labeling Assay. For the
sample preparation, we used Ambion WT expression kit (Life tech-
nologies) and GeneChip WT Terminal Labeling and Controls Kit
(Affymerix); 10,000 ng of cRNA was used for the second cycle cDNA
reaction, and 5500 ng of the second cycle cDNA was fragmented and
then labeled using GeneChip WT Terminal Labeling and Controls Kit.
One mL of the fragmented and 1 mL of the fragmented and
Figure 1 Experimental design. Human umbilical
vein endothelial cells (HUVEC) from passage
2 were cultured either in medium contain-
ing euglycemic glucose concentration of 5.5 mM
or in a hyperglycemic glucose concentration of
16.5 mM. After 24 hr, the euglycemic cultures and
a portion of the hyperglycemic cultures were
treated with 150 mM CoCl2 to induce chemical
hypoxia. Then, RNA was extracted for gene ex-
pression analysis performed with microarrays and
qRT-PCR.
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subsequently labeled cDNA were subjected to 3% agarose gel electro-
phoresis to determine fragmentation size, which usually ranged be-
tween 40 and 70 bp. Hybridization cocktails containing fragmented
and end-labeled cDNA were applied to the Gene Chip Human Gene
1.0 ST arrays. Hybridization was performed for 17 6 1 hr in the
GeneChip Hybridization oven 640 at 45 and 60 rpm. Three different
biological replicates were hybridized for each experimental condition,
resulting in a total of 33 microarray experiments. Arrays were washed
and stained using GeneChip Fluidics Station 450 FS450_007 Fluidics pro-
file. The arrays were scanned using Affymetrix GeneChip scanner 3000 7G.
Gene expression analysis
Affymetrix .CEL files were imported to Partek Genomics Suite version
6.6 (Partek Inc., St. Louis, MO). The data were normalized using robust
multi-array average (RMA) normalization. Principal component anal-
ysis (PCA) was performed on all probes to visualize high dimensional
data. A list of genes with gene expressions between 21.2-fold and 1.2-
fold change was generated using ANOVA. Ten candidate reference
genes that have been previously utilized in different studies under
hypoxic conditions (Foldager et al. 2009; Bruge et al. 2011; Tan et al.
2012) were selected from our microarray data and then ranked by
using NormFinder software (Andersen et al. 2004). NormFinder gen-
erated different stability values for a given set of candidate genes;
a lower value implies higher stability in gene expression. The
microarray data generated in this study were in compliance
with MIAME (http://www.mged.org/Workgroups/MIAME/miame.
html) guidelines. The complete dataset and associated experimental
information have been submitted to NCBI’s Gene Expression Omni-
bus (GEO; http://www.ncbi.nlm.nih.gov/geo/) and are accessible
through accession number GSE46263.
Reverse-transcription reaction
Complementary DNA (cDNA) was synthesized using First-Strand
cDNA Synthesis Kit (GE Healthcare, Little Chalfont, UK) according
to the manufacturer’s guidelines. A solution of 20 ml RNA in RNase-
free water with total RNA concentration of 500 ng was heated to 65
for 10 min. Subsequently, 11 ml of the bulk first-strand cDNA reaction
mix, 1 ml of DTT solution, and 1 ml of random hexadeoxynucleotides
primer were added to heat-denatured RNA. The samples were incu-
bated for 1 hr at 37.
Real-time PCR
Primers were designed using the NCBI primer blast tool (http://www.
ncbi.nlm.nih.gov/tools/primer-blast/) and were procured fromMetabion
(Steinkirchen, Germany). Primer sequences are listed in Table 1.
The PCR mixture contained 1 ml of diluted cDNA, 10 ml of 2·
Fast SYBR Green Master Mix (Life Technologies, Grand Island, NY),
and 10 mM of each gene-specific primer in a total volume of 20 ml.
Real-time reactions were performed in triplicates in 96-well optical
reaction plates (Life Technologies) using StepOne Plus Real-Time
PCR System (Life Technologies) under the following conditions:
20 sec at 95, followed by 40 cycles of 3 sec at 95, 30 sec at 60,
and 15 sec at 72. Four different HUVECs were used for each
condition.
Statistical analysis
Mean expression values of each triplicate were calculated using the
22ΔCT method, a modification of the 22ΔΔCT method described earlier
(Livak and Schmittgen 2001), wherein ΔCt = Ct(sample)2 Ct(control) and
control is the sample without treatment. Expression values are pre-
sented as mean 6 SEM. The comparisons of gene expression levels
n Table 1 PCR primers used in validation of gene expression by qRT-PCR
Gene-Specific Primers Oligonucleotide Primer Sequence 59 to 39 Primer Length (bp) Product Size (bp) Tm (C)
RPLPO Fw CCATTCTATCATCAACGGGTACAA 24 75 62
Rw TCAGCAAGTGGGAAGGTGTAATC 23 63
GAPDH Fw GCCATCAATGACCCCTTCAT 20 81 58
Rw GCCATGGAATTTGCCAT 17 50
GUSB Fw CTACATCGATGACATCACCGTCAC 24 80 65
Rw TGCCCTTGACAGAGATCTGGTAA 23 63
TFRC Fw GTCGCTGGTCAGTTCGTGATT 21 80 61
Rw AGCAGTTGGCTGTTGTACCTCTC 23 65
ACTB Fw CCCTGGCACCCAGCAC 16 71 58
Rw GCCGATCCACACGGAGTAC 19 62
n Table 2 NormFinder microarray expression stability analysis
Gene Name
Hypoxia
Stability Value
Hyperglycemia/Hypoxia
Stability Value Lower log2-Intensity Upper log2-Intensity
RPLP0 0.008 0.004 13.05 13.31
GAPDH 0.008 0.005 13.81 14.05
RPLP2 0.009 0.005 13.03 13.18
ACTB 0.010 0.005 13.28 13.56
HPRT1 0.015 0.008 9.14 9.77
GUSB 0.016 0.008 8.92 9.65
TFRC 0.018 0.012 10.63 11.40
ATP5F1 0.019 0.010 7.20 7.94
B2M 0.020 0.012 10.44 11.58
RPL13A 0.023 0.028 9.86 11.18
Gene expression in the microarray was calculated by log2-intensity values of the genes. NormFinder transforms log to linear scale and ranks
the candidate genes according to their expression stability, where a lower value indicates a higher stability in gene expression. The stability of
genes was ranked into two groups, hypoxia for different time points (1, 3, 12 hr) and hyperglycemia/hyperglycemia combined with hypoxia
for different time points (1, 3, 12 hr).
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between qRT-PCR results were performed using paired t-test. Calcu-
lations were performed using SPSS software version 19.0 (SPSS Inc).
P , 0.05 was considered statistically significant.
RESULTS
RNA quality analyses showed RNA integrity values (RIN) of 9.1–10.
The algorithm assigns an RIN number score from 1 to 10, where level
10 represents completely intact RNA and 1 represents a highly
degraded RNA.
Expression levels of candidate reference genes
by microarray
Microarray data (.CEL files) from three independent biological
replicates were analyzed using Partek Genomics Suite version 6.6.
Agglomerative average was performed and genes showing expressions
between21.2-fold and 1.2-fold change were considered stable. There-
fore, a list of reference genes was generated by filtering genes that are
stable under each condition (P. 0.05). We identified 9235 genes with
no significant variation across all conditions. To narrow-down the
number of candidate reference genes for all eight different condi-
tions tested in our study, we selected 10 common reference genes to
identify their stability values by using the NormFinder software
(Table 2). Under hypoxia as well as under hyperglycemia and hyper-
glycemia combined with hypoxia for different time intervals (1, 3, and
12 hr), RPLP0 was predicted to be the most stable expressed reference
gene. Based on NormFinder analysis, we selected RPLP0, ACTB,
GAPDH, GUSB, and TFRC for further qRT-PCR validation (Table 3).
TFRC and RPLP0 mRNA expression were stable in
HUVEC-induced by hypoxia
Expression values of the five chosen reference genes were validated in
four independent cDNA preparations. Under hypoxic conditions, the
expression of ACTB was found to be stable after 1 hr of hypoxia
compared with the control but significantly downregulated after 3 and
12 hr of hypoxia compared with the control (P = 0.01 and P = 0.009,
respectively) (Figure 2). The expression of GUSB was found to be
inhibited (P = 0.05), whereas GAPDH was upregulated with a borderline
significance (P = 0.05) after 12 hr of hypoxia compared with the control
(5.5 mM glucose). In contrast, TFRC and RPLP0 displayed stable ex-
pression under hypoxia in all intervals (1, 3, and 12 hr) compared with
the control.
GUSB, TFRC, RPLP0, and ACTB mRNA expression were
stable in HUVEC induced by hyperglycemia and hypoxia
When HUVEC were treated under hyperglycemic conditions (16.5
mM glucose) for 24 hr, the five selected reference genes demonstrated
stable expression (Figure 3). Under hyperglycemia combined with
hypoxia, gene expression of GUSB, TFRC, RPLP0, and ACTB turned
out to be stable (Figure 3) in all time intervals measured (1, 3, and
12 hr). In contrast, an increase in gene expression of GAPDH was
revealed with a borderline significance (P = 0.05) after 12 hr of hypoxic
incubation compared with the control.
DISCUSSION
Better understanding of the cellular and molecular responses to hypoxia
and hyperglycemia can lead to improved treatment of CVD in patients
with diabetes. Myocardial infarction due to occlusion of one of the
coronary arteries is frequently observed in such patients (Michiels
2004). Translational cardiovascular research in vitro requires an exper-
imental design that reflects clinical conditions in patients to identify the
affected genes. n
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In our in vitro studies, we investigated the conditions that are known
to be associated with acute myocardial infarction under diabetic and
nondiabetic conditions. We induced hypoxia using a hypoxia-mimetic
agent, CoCl2. Earlier studies have shown that CoCl2 is able to generate
a similar transcriptional response to reduced oxygen tension using
hypoxia incubators (Vengellur et al. 2003; Poulios et al. 2006). The
CoCl2 method has the advantage of being fast and inexpensive and
provides a more stable hypoxia that is not possible with hypoxic cham-
bers (Wu and Yotnda 2011). Our experiments show typical hypoxia
response genes such as hypoxia-inducible factor-1a (HIF1a), vascular
endothelial growth factor A (VEGFA), and glucose transporter 1
(GLUT1) to be overexpressed in hypoxia induced by CoCl2 (data
submitted to GEO database), making our results comparable with
low O2 tension experiments (Liu et al. 1999; Wang et al. 2007).
To mimic diabetic conditions, moderate hyperglycemia (16.5 mM
glucose) was used. We avoided the commonly used excessive high
glucose concentrations (22 mM) that have been shown to impair
cellular growth in tissue culture. With 16.5 mM glucose concentration,
no such effect was observed (Altannavch et al. 2004). A 16.5-mM
glucose concentration not only is known to simulate a diabetic state
but also is associated with hyperglycemia-mediated vascular inflamma-
tion through increased expression of endothelial adhesion molecules,
such as endothelial-leukocyte adhesion molecule 1 (ELAM-1), vascular
cell adhesion molecule-1 (VCAM-1), and intercellular adhesion
molecule-1 (ICAM-1) (Takami et al. 1998; Altannavch et al. 2004). Our
hyperglycemia experiments showed very high expression of thioredoxin
interacting protein (TXNIP) in microarray results (data not shown).
TXNIP has been recently shown to be a key mediator in hyperglycemia-
mediated inflammatory response and beta-cell apoptosis (Minn et al.
2005; Zhou et al. 2010). Different exposure times to hypoxic and/or
hyperglycemic conditions were selected to simulate both early and late
cellular and molecular responses following ischemia (Thygesen et al.
2007). Of note, a qRT-PCR study of HUVEC cultured for 48 hr under
different hypoxic conditions (1% O2, 5% CO2, with balanced N2,
or 150 mM CoCl2) has demonstrated that human ATP synthase,
H-transporting, mitochondrial F0 complex, subunit B1 (ATP5F1), RPLP0,
and ribosomal protein large P2 (RPLP2) were suitable reference genes
(Hatipoglu et al. 2009). In contrast, we applied shorter incubation
times (1, 3, and 12 hr) and identified two reference genes, namely
RPLP0 and TFRC, as the most stably expressed under both euglycemia
and hyperglycemia, in the presence or absence of hypoxia. In our
results, two commonly perceived reference genes GAPDH and ACTB
displayed significant differences in their expression levels under various
hypoxic conditions. These results match an earlier study of
Figure 2 Effect of euglycemia and hypoxia on
gene expression of the selected reference genes.
Fold change in gene expression analyzed by the
22ΔCT method. Data are mean6 SEM, n = 4, P,
0.05, P , 0.01 vs. control. Expression of GUSB
and GAPDH was shown borderline significance
after 12 hr of hypoxia, whereas ACTB was signifi-
cantly changed after 3 and 12 hr of hypoxia. In
contrast, the gene expression of RPLP0 and TFRC
was found to be stable compared with control.
Figure 3 Effect of hyperglycemia and hypoxia
on gene expression of the selected reference
genes. Fold change in gene expression analyzed
by the 22ΔCT method. Data are mean6 SEM, n =
3–4, P , 0.05 vs. control. Expression of GUSB,
TFRC, RPLP0, and ACTB was found to be stable,
whereas GAPDH was increased with borderline
significance after 12 hr of hypoxia compared with
the control.
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bovine endothelial cells maintained in a humidified chamber flushed
with 3% O2, where GAPDH showed unstable expression levels with
a significant increase after 2–4 hr and a maximum level at 18 hr of
hypoxia (Graven et al. 1994). From 9235 genes that were found
stable in all studied conditions in microarray experiments, we ana-
lyzed 10 common reference genes using NormFinder. The Norm-
Finder results showed RPLP0 as the most stable reference gene that
matches with our qRT-PCR data. However GAPDH and ACTB
identified using the NormFinder as highly stable reference genes
in hyperglycemia and hypoxia combined were not found in our
validation by qRT-PCR. This difference in reference genes identified
by microarray data using NormFinder and qRT-PCR could be due
to nonconcordance of transcripts used in the microarray probe set
and qRT-PCR (Dallas et al. 2005). The TFRC and RPLP0 identified
by us have been previously reported as reference genes in other cell
types, including dexamethasone-exposed breast cancer cells and
CD19-positive chronic lymphocytic leukemia cells (Abruzzo et al.
2005; Majidzadeh et al. 2011). Therefore, this is the first report in-
dicating TFRC and RPLP0 as suitable reference genes in HUVEC
exposed to hypoxia, hyperglycemia, or hypoxia and hyperglycemia
combined.
In summary, our data indicate not only that TFRC and RPLP0 are
suitable reference genes to normalize gene expression level in qRT-
PCR experiments in hypoxic and/or hyperglycemic HUVEC cultures
but also that commonly known reference genes always need to be
validated for the given experimental conditions.
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